Thieler Law Corp, member of the Investor Attorney Network, is investigating whether members of the board of directors of Cogentix Medical Inc (NASDAQ: CGNT) acted responsibly on behalf of investors’ profitability in the planned sale to LABORIE Medical Technologies Inc.

On March 12, 2018, Cogentix Medical Inc (NASDAQ: CGNT) and LABORIE Medical Technologies Inc announced that they had entered into a merger agreement. Under the terms of the merger agreement, LABORIE Medical will offer Cogentix Medical shareholders $3.85 per share in cash for all outstanding shares.    

Based in Minnetonka, Minnesota, and founded in 1987 Cogentix Medical Inc a medical device company, designs, develops, manufactures, and markets fiberoptic and video endoscopy products under the PrimeSight brand worldwide.

The investigation is looking to uncover whether Cogentix Medical Inc was undervalued at the cost of the shareholders considering one analyst’s opinion of their stock is valued at $5.00 per share.

If you purchased Cogentix Medical Inc (NASDAQ: CGNT) prior to March 12, 2018, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185